William Blair Downgrades AptarGroup to Market Perform
William Blair downgrades AptarGroup (NYSE:ATR) from Outperform to Market Perform.
AptarGroup Q2 EPS $0.91 Misses $0.96 Estimate, Sales $811.03M Beat $774.81M Estimate
AptarGroup (NYSE:ATR) reported quarterly earnings of $0.91 per share which missed the analyst consensus estimate of $0.96 by 5.21 percent. This is a 13.75 percent increase over earnings of $0.80 per share from the same
Earnings Scheduled For July 29, 2021
Companies Reporting Before The Bell
• Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter.
AptarGroup Partners With Chinese Skincare Company YAT
Drug delivery devices manufacturer AptarGroup Inc (NYSE:ATR) is collaborating with YAT, a Chinese Online Skincare Company, to develop a range of…
AptarGroup Reports Strategic Collaboration With YAT To Develop Range Of Products, Services For Skincare Market, No Terms Disclosed
AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science, and YAT, a multi-functional, science-driven online skincare solutions company, have announced a
BMO Capital Maintains Outperform on AptarGroup, Raises Price Target to $167
BMO Capital analyst Mark Wilde maintains AptarGroup (NYSE:ATR) with a Outperform and raises the price target from $158 to $167.